CYTOMEGALOVIRUS PNEUMONITIS AFTER CARDIAC TRANSPLANTATION

被引:21
|
作者
SCHULMAN, LL
REISON, DS
AUSTIN, JHM
ROSE, EA
机构
[1] COLUMBIA UNIV COLL PHYS & SURG, DEPT RADIOL, NEW YORK, NY 10032 USA
[2] COLUMBIA UNIV COLL PHYS & SURG, DEPT SURG, NEW YORK, NY 10032 USA
关键词
D O I
10.1001/archinte.151.6.1118
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To evaluate the incidence and clinical features of cytomegalovirus (CMV) pneumonitis after cardiac transplantation, we identified 27 (16%) of 171 consecutive recipients in whom CMV pneumonitis was confirmed by strict diagnostic criteria. Cytomegalovirus pneumonitis occurred in 6 (30%) of 20 patients treated with azathioprine and prednisone, and 8 (25%) of 32 patients treated with azathioprine, cyclosporine, and prednisone, but only 13 (11%) of 119 patients treated with cyclosporine and prednisone. The incidence of CMV pneumonitis was not related to recipient preoperative CMV titers or to postoperative cardiac rejection, but there was a trend toward increased CMV pneumonitis in patients who received organs from CMV-positive donors. Mean onset of CMV pneumonitis was 2.9 +/- 1.6 (SD) months after transplantation. In the azathioprine-prednisone group, CMV was always associated with at least one other respiratory pathogen (Aspergillus, n = 5; Pneumocystis carinii, n = 2). In the two cyclosporine groups, CMV was either the sole respiratory pathogen (n = 9), or associated with P carinii (n = 11). Roentgenographically, diffuse bilateral hazy pulmonary opacities were present in 19 (70%) of 27 patients, but focal subsegmental opacity (26%), small pleural effusion (26%), and lobar consolidation (7%) were also observed. When bronchoscopy was performed, bronchoalveolar lavage was the most sensitive technique for detecting CMV (72%), whereas transbronchial biopsy (39%) and combined washings and brushings (33%) were relatively insensitive techniques. Respiratory failure and death occurred in 52% and 44%, respectively, of patients with CMV pneumonitis. In this population of immunocompromised hosts: (1) CMV pneumonitis, alone or with other respiratory pathogens, was a major cause of morbidity and mortality; (2) localized roentgenographic opacity did not exclude CMV pneumonitis; (3) bronchoalveolar lavage was the most sensitive bronchoscopic technique for detecting CMV pneumonitis.
引用
收藏
页码:1118 / 1124
页数:7
相关论文
共 50 条
  • [21] Fatal Cytomegalovirus Pneumonitis and Ileitis in a Patient with a Cardiac Assist Device
    Huttner, Benedikt
    Reineke, Tanja
    Wilhelm, Markus J.
    Karrer, Urs
    AMERICAN SURGEON, 2011, 77 (09) : E182 - E183
  • [22] BRONCHO ALVEOLAR-LAVAGE CELLS IN CYTOMEGALOVIRUS PNEUMONITIS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    CORDONNIER, C
    BERNAUDIN, JF
    FLEURY, J
    POCHOLLE, MJ
    ATASSI, K
    GARCIA, J
    VERNANT, JP
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1983, 127 (04): : 204 - 204
  • [23] MODIFICATION OF CYTOMEGALOVIRUS RISK IN CARDIAC TRANSPLANTATION
    ODONNELL, JA
    TURRENTINE, MW
    KESLER, KA
    HANOSH, JJ
    MAHOMED, Y
    FAUST, S
    BROWN, JW
    CIRCULATION, 1992, 86 (04) : 38 - 38
  • [24] Influence of cytomegalovirus infection in the development of cardiac allograft vasculopathy after heart transplantation
    Delgado, Juan F.
    Garcia Reyne, Ana
    de Dios, Santiago
    Lopez-Medrano, Francisco
    Jurado, Alfonso
    San Juan, Rafael
    Jose Ruiz-Cano, Maria
    Dolores Folgueira, M.
    Angel Gomez-Sanchez, Miguel
    Maria Aguado, Jose
    Lumbreras, Carlos
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (08): : 1112 - 1119
  • [25] THE IMPACT OF BLOOD-TRANSFUSION ON THE OCCURRENCE OF PNEUMONITIS IN PRIMARY CYTOMEGALOVIRUS-INFECTION AFTER LIVER-TRANSPLANTATION
    MANEZ, R
    KUSNE, S
    MARTIN, M
    LINDEN, P
    IRISH, W
    TORRECISNEROS, J
    KRAMER, D
    HO, M
    STARZL, TE
    TRANSFUSION, 1993, 33 (07) : 594 - 597
  • [26] Cytomegalovirus pneumonitis, activated prothrombin time prolongation and subacute thyroiditis after unrelated allogeneic bone marrow transplantation
    Kawano, C
    Muroi, K
    Akioka, T
    Izumi, T
    Kodera, Y
    Ozawa, K
    BONE MARROW TRANSPLANTATION, 2000, 26 (12) : 1347 - 1349
  • [27] Cytomegalovirus pneumonitis, activated prothrombin time prolongation and subacute thyroiditis after unrelated allogeneic bone marrow transplantation
    C Kawano
    K Muroi
    T Akioka
    T Izumi
    Y Kodera
    K Ozawa
    Bone Marrow Transplantation, 2000, 26 : 1347 - 1349
  • [28] Cytomegalovirus pneumonitis in the mouse
    Hammerschmidt, DE
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1998, 132 (02): : 166 - 166
  • [29] Cytomegalovirus Specific Immunity in Paediatric Cardiac Transplantation
    Jacobsen, M. C.
    Manunta, M. D. I.
    Pincott, E. S.
    Klein, N. J.
    Burch, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04): : S150 - S150
  • [30] Specific Immunity to Cytomegalovirus in Pediatric Cardiac Transplantation
    Jacobsen, Marianne C.
    Manunta, Maria D. I.
    Pincott, Emma S.
    Fenton, Matthew
    Simpson, Gavin L.
    Klein, Nigel J.
    Burch, Michael
    TRANSPLANTATION, 2018, 102 (09) : 1569 - 1575